Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN)-Reference-Cited by-同舟云学术

Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN)

Published:2015-05 Issue:5 Volume:51 Page:399-408
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Price Katharine A.R.,Cohen Ezra E.W.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference118 articles.

1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology™. Head and Neck Cancers. V.2.2014. .

2. Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck;Cohen;J Clin Oncol,2006

3. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival;Rubin Grandis;J Natl Cancer Inst,1998

4. The nuclear epidermal growth factor receptor signaling network and its role in cancer;Brand;Discov Med,2011

5. Blockade of the HER family of receptors in the treatment of HER2-positive metastatic breast cancer;Sachdev;Clin Breast Cancer,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characterization of SPATA6 and association of its SNPs with testicular size in sheep;Theriogenology;2024-02

2. The Tumour Suppressor CYLD Is Required for Clathrin-Mediated Endocytosis of EGFR and Cetuximab-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma;Cancers;2021-12-30

3. Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck;Cancers;2021-07-15

4. Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response;Journal of Translational Medicine;2021-01-23

5. Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review;Archives of Medical Science;2021-01-05